Caitlin E. Mills

A single-cell landscape of high-grade serous ovarian cancer

Benjamin Izar, Itay Tirosh, Elizabeth H. Stover et al. · Nature Medicine · 2020 · 522 citations · Full text

Medicine, Cell Biology, Oncology +14

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

Marc Hafner, Caitlin E. Mills, Kartik Subramanian et al. · Cell chemical biology · 2019 · 255 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Targeting TBK1 to overcome resistance to cancer immunotherapy

Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 167 citations · Full text

Medicine, Cancer Biology, Oncology +12

Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype

Yanke Liang, Alan L. Leggett, Woojun D. Park et al. · Cell chemical biology · 2019 · 165 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines

Mario Niepel, Marc Hafner, Caitlin E. Mills et al. · Cell Systems · 2019 · 143 citations · Full text

Medicine, Cell Biology, Oncology +13